Stevens-Johnson syndrome induced by Sintilimab: a case report and literature review
{{output}}
Background: Skin diseases induced by Sintilimab, a programmed cell death protein-1 (PD-1) inhibitor, are rare, with only 28 cases reported. We provide a literature review on skin diseases associated with Sintilimab and summarize ... ...
